Itruvone

Itruvone (INNTooltip International Nonproprietary Name; developmental code name PH10), also known as pregn-4-en-20-yn-3-one, is a vomeropherine which is under development by VistaGen Therapeutics as a nasal spray for the treatment of major depressive disorder.
Wikipedia contributors, "Itruvone", Wikipedia, revision 1372021701, retrieved 20 November 2026, source, CC BY-SA 4.0.